Introduction
Dendritic spines are small protrusions from the dendrite that form the postsynaptic component of excitatory synapses. Filopodia are recognized as one origin of dendritic spines (for reviews see Hering and Sheng, 2001; Ethell and Pasquale, 2005) . During early stages of synaptogenesis, fi lopodia rapidly protrude and retract from dendrites. When dendritic fi lopodia contact presynaptic sites and form synapses, filopodia contract and transform into dendritic spines. Many transmembrane receptors and intracellular molecules have been shown to play a role in spinogenesis (for reviews see Hering and Sheng, 2001; Carlisle and Kennedy, 2005; Ethell and Pasquale, 2005; Lippman and Dunaevsky, 2005; Tada and Sheng, 2006) , including syndecan-2.
Syndecan-2 belongs to the syndecan family of transmembrane heparan sulfate proteoglycans. By virtue of their heparan sulfate modifi cations, syndecans act as coreceptors for growth or differentiation factors, presenting these molecules to specifi c receptor tyrosine kinases, including the fi broblast growth factor receptors (Filla et al., 1998) . Syndecans also function as adhesion molecules that regulate cell migration, cell-cell interactions, and cell-extracellular matrix interactions (Klass et al., 2000; Beauvais et al., 2004; Reiland et al., 2004) . During neural development, syndecan-2 expression is elevated during synaptogenesis (Ethell and Yamaguchi, 1999; Hsueh and Sheng, 1999a) . The overexpression of syndecan-2 starting at 1 d in vitro (DIV) accelerates spine formation in hippocampal neurons examined at 8 DIV (Ethell and Yamaguchi, 1999) , suggesting a role of syndecan-2 in spinogenesis. Because syndecan-2 overexpression also promotes fi lopodia formation in nonneuronal cell lines such as COS-1 and Swiss 3T3 (Granes et al., 1999 (Granes et al., , 2000 , it is possible that syndecan-2 fi rst promotes fi lopodia formation and, consequently, transforms fi lopodia into dendritic spines in neurons.
Syndecan-2 induces fi lopodia and dendritic spine formation via the neurofi bromin-PKA-Ena/VASP pathway As yet, the molecular mechanism underlying the effect of syndecan-2 on cytoskeleton rearrangement remains unclear. Although the cytoplasmic domain of syndecan-2 is short ‫03ف(‬ residues) and has no kinase domain, several syndecan-2-interacting proteins have been identifi ed whose activity may provide clues about syndecan-2 signaling. The cytoplasmic domain of syndecan-2 consists of three small regions: two highly conserved regions (C1 and C2) and, between these, a variable (V) region unique to each syndecan. The C2 region contains a type II PDZ-binding motif (residues E-F-Y-A; Cohen et al., 1998; Hsueh et al., 1998) . This EFYA motif is important for syndecan-2dependent dendritic spine formation, and syndecan-2 loses the ability to promote spinogenesis when the C2 motif is removed (Ethell and Yamaguchi, 1999) . Several adaptor proteins such as syntenin, calcium/CaM-dependent serine protein kinase (CASK), synbindin, and synectin all bind to the EFYA motif of syndecans (Grootjans et al., 1997; Cohen et al., 1998; Hsueh et al., 1998; Ethell et al., 2000; Gao et al., 2000) , suggesting that these interactions play a role in synaptic formation.
Another syndecan-2-interacting protein is neurofi bromin (Hsueh et al., 2001) , which is encoded by the neurofi bromatosis type 1 (NF1) gene and interacts with the C1 region of syndecan-2. 40-60% of NF1 patients are characterized as having specifi c learning disabilities (for reviews see Rosser and Packer, 2003; Acosta et al., 2006) . Mice carrying a heterozygous null mutation of the NFl gene also show several features of the learning deficits associated with NF1 mutations in humans (for review see . These studies indicate an important role of neurofi bromin in neuronal function. At the molecular level, neurofi bromin possesses a central Ras GTPase-activating protein-related domain that regulates the Ras-MAPK pathway (for reviews see Cichowski and Jacks, 2001; Zhu and Parada, 2001) . In addition, neurofi bromin is also involved in the cAMP pathway via the regulation of adenylyl cyclase through two distinct pathways (Tong et al., 2002; Dasgupta et al., 2003; Hannan et al., 2006) . One is the receptor tyrosine kinase pathway, which acts independently of any heterotrimeric G protein; Ras activation by neurofi bromin is essential for this pathway. The other is the classic heterotrimeric G-protein pathway, which is Gα s dependent and requires the C-terminal region of neurofi bromin (Hannan et al., 2006) .
In this study, we elucidate the role of these intracellular interactions of syndecan-2 in neuronal morphogenesis. Filopodia formation in nonneuronal cells was chosen here as a model to study the early downstream signaling of syndecan-2. The common signaling of the syndecan-2-neurofi bromin-PKA-Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) pathway leading to fi lopodia formation and spinogenesis was then studied in cultured hippocampal neurons. Our study provides the fi rst evidence that neurofi bromin is required for dendritic spine formation, which may explain how NF1 mutation leads to defi cits in learning and memory.
Results

Syndecan-2 is essential for dendritic spine formation
To confi rm that syndecan-2 is important for dendritic spine formation, we used an RNAi approach to reduce neuronal syndecan-2 protein levels. First, we examined the ability of syndecan-2 small hairpin RNA (shRNA) to knock down syndecan-2. Syndecan-2 shRNA but not vector control (SUPER.neo+GFP) effi ciently down-regulated syndecan-2 protein expression in both human embryonic kidney (HEK) 293T cells and cultured hippocampal neurons (Fig. S1, A and B; available at http://www.jcb.org/cgi/ content/full/jcb.200608121/DC1). The effect of syndecan-2 shRNA on dendritic spine formation was then investigated. Constructs expressing syndecan-2 shRNA (also expressing GFP) and GFP-actin were cotransfected into hippocampal neurons at 11 DIV. Morphology of dendritic protrusions was then assessed by GFP and GFP-actin signals. At 16 DIV, dendritic spines in our cultures had differentiated and exhibited Figure 1 . Syndecan-2 is important for dendritic spine formation. (A-C) Cultured hippocampal neurons were cotransfected with vector control SNG (pSUPER.neo+GFP) and EGFP-actin (DNA ratio 2:1; A), syndecan-2 shRNA and EGFP-actin (DNA ratio 2:1; B), and syndecan-2 shRNA, EGFP-actin, and syndecan-2 silent mutant resistant to syndecan-2 shRNA (DNA ratio 6:1:6; C). The GFP and GFP-actin signals were then viewed to assess cell morphology. The insets are the magnifi ed images of the boxed areas. Bar, 10 μm. (D) Quantitative analysis of the effects of syndecan-2 shRNA on spine formation as described in Materials and methods. The cumulative probability distributions of protrusion density along dendrites are shown. characteristics of mature spines ( Fig. 1 A, inset) . In the presence of syndecan-2 shRNA, the number of dendritic protrusions representing dendritic spines was greatly reduced (Fig. 1, B and D). To ensure the sequence-specifi c effect of syndecan-2 shRNA, a syndecan-2 silent mutant insensitive to syndecan-2 shRNA was coexpressed with syndecan-2 shRNA ( Fig. 1 C) . Overexpression of the silent mutant did rescue the effect of syndecan-2 shRNA on protrusion number (Fig. 1 D) . In addition, mature spines were observed along the dendrites in the presence of syndecan-2 mutant ( Fig. 1 C, inset) . These results support a critical role for syndecan-2 in dendritic spine formation.
Because dendritic fi lopodia have been proposed to be precursors of dendritic spines and syndecan-2 has been shown to induce fi lopodia formation in nonneuronal cells (Granes et al., 1999 (Granes et al., , 2000 , it is likely that the overexpression of syndecan-2 in cultured hippocampal neurons fi rst induces fi lopodia formation and then promotes dendritic spine maturation. Indeed, when syndecan-2 was transfected into cultured hippocampal neurons at 1 DIV, numerous fi lopodia emerging from dendrites were observed at 4-5 DIV (Fig. 2 C) . Because fi lopodia formation induced by syndecan-2 also occurs in nonneuronal cells, this initial process involved in dendritic spinogenesis does not appear to be neuron specifi c, although the transformation from fi lopodia to spines should be specifi c for neurons. To explore the signaling downstream of syndecan-2 that initiates spine formation, we fi rst used fi lopodia formation in nonneuronal HEK cells as a model system for syndecan signaling and confi rmed these observations in cultured hippocampal neurons.
Downstream signaling of syndecan-2
To monitor syndecan-2 expression and cell morphology of transfected cells, we generated the syndecan-2 antibody syndecan-2G. For cells transfected with syndecan-2, immunostaining using the syndecan-2G antibody was performed. For cells transfected with GFP, immunostaining was skipped. PKA inhibitors KT5720 and H89 were added to the culture 16 (O/N), 6, or 3 h before harvesting as indicated. (B) Cumulative probability distributions of fi lopodia density in A were analyzed as described in Materials and methods. (C) PKA is involved in syndecan-2-induced fi lopodia in neurons. Syndecan-2, GFP, and GFP-actin were transfected into cultured hippocampal neurons at 1 DIV. 3-4 d later, cells were fi xed and subjected to immunostaining. H89 (at a fi nal concentration of 10 μM) was added 12 h before harvest. (D) Cumulative probability distributions of the fi lopodia density in C. Bars, 10 μm.
This antibody was confi rmed as recognizing syndecan-2 (Fig. S2, A and B; available at http://www.jcb.org/cgi/content/full/ jcb.200608121/DC1) but not syndecan-1, -3, or -4 ( Fig. S2 A) in both immunoblotting and immunostaining experiments in transfected COS cells, confi rming its high syndecan-2 specifi city.
Generally, there are very few fi lopodia on the surface of parental HEK cells (<0.2 fi lopodia per μm; Fig. 2 B) . When syndecan-2 was overexpressed in HEK293T cells, numerous fi lopodia were revealed by syndecan-2G antibody (Fig. 2 A) . Cotransfection of syndecan-2 and GFP into HEK cells was also performed (unpublished data). Perhaps as a result of staining of the plasma membrane, we found that syndecan-2 signal outlined the morphology of HEK cells more clearly than GFP signal. To explore the downstream signaling of syndecan-2, several kinase inhibitors were added to cultures overexpressing syn decan-2, including the phosphatidylinositol 3-kinase (PI3K) inhibitors LY294002 and wortmannin, PKC inhibitors Go6976 and Go6850, and PKA inhibitors KT5720 and H89. Neither PIK3 nor PKC inhibitors prevented fi lopodia formation induced by syndecan-2 ( Fig. S3 , available at http://www.jcb.org/cgi/content/ full/jcb.200608121/DC1), suggesting that syndecan-2-induced fi lopodia formation is independent of the PI3K-Akt and PKC pathways. In contrast, both PKA inhibitors KT5720 and H89 decreased syndecan-2-induced fi lopodia formation (Fig. 2, A  and B ), although the effect of KT5720 was weaker than that of H89 for unknown reasons. To further confi rm that PKA is involved in syndecan-2 signaling, a construct expressing the PKA-specifi c peptide inhibitor PKI was cotransfected with syndecan-2 into HEK cells. The presence of PKI signifi cantly reduced the fi lo podia density on the surface of syndecan-2-expressing HEK293T cells (P < 0.001; Fig. 2, A and B) , sup porting the idea that PKA signaling is important for syndecan-2-induced fi lopodia formation in HEK293T cells.
Results for cultured hippocampal neurons were similar to those in HEK293T cells: PKA inhibitor H89 effi ciently reduced the number of syndecan-2-induced fi lopodia along neurites (Fig. 2, C and D) . These results indicated that syndecan-2 induces dendritic fi lopodia formation via PKA in cultured hippocampal neurons.
Involvement of the syndecan-2 C1 region in fi lopodia formation
A series of C-terminal mutants of syndecan-2 ( Fig. 3 A) were then used to map the cytoplasmic regions of syndecan-2 that are required for fi lopodia formation. Mutant genes were transfected into HEK293T cells, and immunoblotting with syndecan-2G antibody confi rmed that expression levels of these mutants were comparable with those of wild-type syndecan-2 ( Fig. S2 C) . In addition, these deletions did not considerably affect the plasma membrane targeting of mutants (unpublished data). The effects of these mutants on fi lopodia formation in HEK293T cells were then examined. The mutant syndecan-2∆3 lacking the last three residues of syndecan-2 successfully induced normal fi lopodia formation (Fig. 3, B and C). The ability of the mutant syndecan-2∆20 lacking the cytoplasmic V and C2 regions to induce fi lopodia was slightly weaker than that of wild-type syndecan-2 ( Fig. 3 , B and C). When the entire cytoplasmic region of syndecan-2 was removed in the syndecan-2∆32 mutant, the ability to form fi lopodia was greatly impaired (Fig. 3, B and C). In the syndecan-2∆C1 mutant lacking only the C1 region, the ability to promote fi lopodia formation was also greatly reduced ( Fig. 3, B and C). These results suggested that both the C1 and V regions (variable region of syndecan) of syndecan-2 are involved in fi lopodia formation in HEK cells, with the C1 region being the most critical.
To confi rm the role of the syndecan-2 C1 region in dendritic fi lopodia formation, wild-type syndecan-2, -2∆C1, and -2∆3 mutants were transfected into cultured hippocampal neurons. Compared with wild-type syndecan-2, the number of dendritic fi lopodia was greatly reduced in neurons expressing syndecan-2∆C1 (Fig. 3 , D and E). In contrast, syndecan-2∆3 still effi ciently induced dendritic fi lopodia formation (Fig. 3 , D and E). These data supported the notion that the C1 region is also critical for syndecan-2-induced fi lopodia formation in neurons.
Because the C1 region of syndecan-2 is the most important region for neurofi bromin interaction and neurofi bromin is involved in both neurite outgrowth (Yunoue et al., 2003) and cAMP signaling, we investigated whether the interaction of neurofi bromin with the C1 region of syndecan-2 mediates signaling from syndecan-2 to PKA. Because mutation of the RKKD motif in the C1 region of syndecan-2 impairs neurofibromin interaction (Hsueh et al., 2001) , we explored this possibility by examining the effects of the alanine replacement mutants syndecan-2 RK/AA and KD/AA on fi lopodia formation. Indeed, the ability of syndecan-2 RK/AA and KD/AA mutants to induce fi lopodia formation was much weaker than that of wild type (Fig. 3 , B and C), suggesting that an interaction with neurofi bromin is involved in fi lopodia formation induced by syndecan-2.
Dynamic analysis of fi lopodia
In addition to characterizing fi lopodia density, we also dynamically analyzed fi lopodia behavior using time-lapse techniques. For syndecan-2-induced fi lopodia, the motility of fi lopodia was generally very low. The length of most fi lopodia did not change substantially during the time recorded (around 10 min; Fig. 4 A): only a small fraction of fi lopodia was altered in length, with a mean velocity of 1.55 ± 0.42 μm/min ( Fig. 4 B) . In contrast, the motility of syndecan-2∆C1-expressing cells was higher. Syndecan-2∆C1-induced fi lopodia frequently extended and withdrew at greater amplitudes ( Fig. 4 A) and at a mean velocity of 1.86 ± 0.39 μm/min ( Fig. 4 B) . The majority (12 out of 15) of syndecan-2∆C1-induced fi lopodia extended or withdrew their tips to lengths >1 μm within 6 min ( Fig. 4 C, middle; red lines). In contrast, only the minority (3 out of 12) of mobile syndecan-2-induced fi lopodia exhibited this ability ( Fig. 4 C, top; red lines). When forskolin (FSK), which increases cAMP levels, was added into culture transfected with syndecan-2∆C1, fi lopodia movement was immediately frozen (Fig. 4 , A and C); only a small fraction still extended or withdrew with a mean velocity of 1.29 ± 0.26 μm/min ( Fig. 4 B) , and the movement amplitude was <1 μm within 6 min ( Fig. 4 C, bottom) . These results indicated that syndecan-2-induced fi lopodia are very stable and that the PKA pathway may play an important role in stabilizing formed fi lopodia. The relative instability of syndecan-2∆C1-induced fi lopodia may account for the lower fi lopodia density shown in Fig. 3 (B and C).
Overexpression of syndecans activates PKA
The aforementioned experiments demonstrated that syndecan-2induced fi lopodia formation was prevented by the addition of PKA inhibitors. Thus, it is possible that the overexpression of syndecan-2 activates PKA and subsequently promotes fi lopodia formation. To test this possibility, we compared PKA activity (measured by ELISA) between cells transfected with syndecan-2 or with control vector. Syndecan-2 overexpression in HEK293T cells resulted in 20-30% increases in total PKA activity compared with the vector control (Fig. 5 ). The mutant syndecan-2∆32, which lacked the entire cytoplasmic domain of syndecan-2, lost the ability to enhance PKA activity (Fig. 5 ). The syndecan-2∆C1 mutant missing the critical C1 region was also unable to activate PKA (Fig. 5) . These results support a model for syndecan-2 activation of PKA via its cytoplasmic C1 region, culminating in fi lopodia formation.
Neurofi bromin is required for fi lopodia formation induced by syndecan-2
To confi rm that neurofi bromin mediates signaling from syndecan-2 to PKA, leading to fi lopodia formation, we used two approaches. The fi rst approach was to interrupt the interaction between neurofi bromin and syndecan-2 by overexpression of the syndecan-2interacting domain of neurofi bromin, the Jn fragment (residues 1,356-1,473), which was identifi ed in a yeast two-hybrid assay (Hsueh et al., 2001) . Interaction between syndecan and neurofi bromin Jn fragments was fi rst confi rmed under mammalian cell culture conditions using coimmunoprecipitation ( Fig. S1 D) . The effect of the Jn fragment on syndecan-2-induced fi lopodia formation was then examined. When the Jn fragment was overexpressed, fi lopodia formation induced by syndecan-2 was greatly reduced in HEK293T cells ( Fig. 6 A) . More important, the Jn fragment also inhibited fi lopodia formation in cultured hippocampal neurons (Fig. 6 , B and C), suggesting an essential role for the interaction between syndecan-2 and neurofi bromin in syndecan-2-induced filopodia formation. Overexpression of the Jn fragment alone did not cause an obvious morphological abnormality of cultured neurons. Neither dendrite number nor the length of dendrites was affected by the Jn fragment (unpublished data), supporting the specific effect of the Jn fragment on syndecan-2-induced filopodia formation. If interrupting the interaction between syndecan-2 and neurofi bromin by adding the Jn fragment prevents PKA activation and, thus, blocks fi lopodia formation, it can be predicted that increasing PKA activity in Jn-expressing cells should restore filopodia formation. Indeed, the addition of FSK restored filopodia formation impaired by the Jn fragment in both HEK293T cells (Fig. 6 A) and cultured hippocampal neurons (Fig. 6, B and C) .
The second approach to investigate the role of neurofi bromin in syndecan-2-induced fi lopodia formation was to downregulate endogenous neurofi bromin expression by RNAi. We fi rst examined the down-regulation of endogenous NF1 expression using an NF1 shRNA construct ( Fig. S1 C) . When syndecan-2 and NF1 shRNA construct were cotransfected into HEK cells, the filopodia density was significantly reduced (P < 0.001; Fig. 7 A) . Similarly, the expression of NF1 shRNA in cultured hippocampal neurons impaired dendritic fi lopodia formation compared with nonsilencer control (Fig. 7, B and C) . Again, to confi rm that the effect of NF1 shRNA is to block the signaling from syndecan-2 to the cAMP-PKA pathway, FSK was added into the cultures transfected with syndecan-2 and NF1 shRNA construct. Adding FSK completely restored the fi lopodia formation in both HEK cells and hippocampal neurons (Fig. 7) . These results supported the notion that neurofi bromin mediates signaling to the cAMP-PKA pathway that is required for syndecan-2-induced fi lopodia formation in neurons.
The aforementioned study demonstrated that PKA is the important downstream effector of syndecan-2 on the induction of fi lopodia formation. We then wondered whether the activation of PKA alone is suffi cient for fi lopodia formation in cultured hippocampal neurons. To address this point, FSK and dibutyryl cAMP were added into young hippocampal neurons HEK293T cells were transfected with syndecan-2 constructs and the vector control as indicated and were harvested for PKA activity assays 18 h after transfection. Data shown are the mean ± SEM (error bars) of relative PKA activities. Statistical analysis was performed by one-way analysis of variance to evaluate the difference between the vector control and the specifi c construct (*, P < 0.05; n = 5). (5 DIV) without the overexpression of syndecan-2. The results showed that FSK and dibutyryl cAMP could not induce fi lopodia formation in the absence of syndecan-2 ( Fig. 8 ), suggesting that although PKA is required for syndecan-2-induced fi lopodia formation, activation of PKA alone is not suffi cient for fi lopodia formation. Multiple signaling provided by syndecan-2 may be involved in fi lopodia formation.
Ena/VASP proteins contribute to syndecan-2-induced fi lopodia formation
We then addressed how PKA conducts the signal from syndecan-2/ neurofi bromin to induce cytoskeleton rearrangement. Previous studies had demonstrated that Ena/VASP proteins, which are important for the formation and elongation of fi lopodia, are regulated by PKA phosphorylation (Aszodi et al., 1999; Hauser et al., 1999; Lebrand et al., 2004) . There are three related Ena/ VASP proteins in vertebrates-mammalian enabled (Mena), VASP, and Ena-VASP-like (EVL)-that are highly related and can function interchangeably (Laurent et al., 1999; Geese et al., 2002; Loureiro et al., 2002) . They promote actin fi lament elongation by interacting with barbed ends and shielding them from capping proteins . Mena, EVL, and VASP all share a conserved PKA phosphorylation site, which is critical for the regulation of their function in actin fi lament elongation . It has been shown that Mena is present at the tip of growth cone fi lopodia (Lanier et al., 1999) , where it is positioned to initiate actin polymerization and promote fi lopodia elongation.
To address whether Ena/VASP is the downstream effector of the syndecan-2-neurofi bromain-PKA pathway, we fi rst examined whether Ena/VASP proteins are present at the tips of syndecan-2-induced fi lopodia. GFP-Mena, -VASP, and -EVL all distributed to the tips of every single fi lopodia in syndecan-2transfected HEK293T cells ( Fig. S4 A, available at http://www .jcb.org/cgi/content/full/jcb.200608121/DC1) as well as cultured neurons ( Fig. 9 A) . These results favor the possibility that Ena/VASP proteins are involved downstream of syndecan-2. To further explore this possibility, we examined VASP phosphorylation at the PKA sites in the presence of syndecan-2. Indeed, syndecan-2 overexpression enhanced the phosphorylation levels of VASP in HEK293T cells, as revealed by immunoblotting using phosphopeptide antibodies specifi cally recognizing PKAphosphorylated VASP (Fig. 9 B) . This data supported the activation of VASP by syndecan-2 overexpression. To address the role of Ena/VASP in syndecan-2-induced fi lopodia formation, FP4-mito and AP4-mito constructs were coexpressed with syndecan-2 in cells. FP4-mito is a fusion containing EGFP, four binding motifs for Ena/VASP proteins, and a mitochondria target sequence (Bear et al., 2000) . This fusion binds and mistargets Ena/VASP protein to mitochondria instead of plasma membrane, reducing the fi lopodia formation activity of Ena/ VASP proteins (Bear et al., 2000; Lebrand et al., 2004) . AP4-mito, which contains a mutation in the Ena/VASP-binding motif and fails to interact with Ena/VASP proteins, was used as a negative control. In both HEK293T cells (Fig. S4 B) and cultured hippocampal neurons (Fig. 9, C and D) , the expression of FP4-mito reduced syndecan-2-induced fi lopodia formation. These results supported the notion that Ena/VASP proteins are the downstream mediators of syndecan-2. The addition of FSK into the culture cotransfected with syndecan-2 and FP4-mito did not prevent the blocking effect of FP4-mito in HEK293T cells (Fig. S4 B) or in cultured hippocampal neurons (Fig. 9, C and D) , supporting the idea that PKA works upstream of Ena/VASP.
Neurofi bromin and Ena/VASP proteins are required for dendritic spine formation
The aforementioned results showed that syndecan-2 promotes fi lopodia formation via an NF1-PKA-Ena/VASP pathway in both HEK293T cells and cultured hippocampal neurons. To further elucidate the involvement of this signaling pathway in dendritic spine formation, we performed three more experiments. First, we examined the requirement of the cytoplasmic region of syndecan-2 in spine formation. Wild-type syndecan-2, -2∆C1, and -2∆3 mutants were transfected into cultured hippocampal neurons at 1 DIV, and their abilities to induce dendritic spine formation were examined at 8-9 DIV. Consistent with previous observations (Ethell and Yamaguchi, 1999) , wild-type syndecan-2 induced dendritic spine formation at 8-9 DIV (Fig. 10 A) . These spines formed functional synapses because they made contact with presynaptic buttons, as revealed by presynaptic marker synaptophysin staining (Fig. 10 A) . For neurons transfected with syndecan-2∆3, the protrusion density was not signifi cantly different from that of wild-type syndecan-2 (P = 0.387; Fig. 10,  A and B) . However, the majority of the protrusions of syndecan-2∆3-expressing neurons still carried the characteristics of fi lopodia (being longer than 2 μm and lacking a head; Fig. 10, A and B) , supporting the idea that syndecan-2∆3 can promote fi lopodia formation; however, the consequent transformation from fi lopodia to spines was prevented. For syndecan-2∆C1, the density of the protrusion was much less than that induced by wild-type syndecan-2 (Fig. 10, A and B) . This outcome was similar to the effect of syndecan-2∆C1 on fi lopodia formation at 4-5 DIV (Fig. 3 D) . These results support the notion that the C1 region of syn decan-2 is required for both fi lopodia and spine formation and that the C2 region is critical for spine formation. The fact that the protrusion densities induced by syndecan-2 and -2∆3 were similar (Fig. 10 B) also supports the hypothesis that fi lopodia are the intermediates of spines in this syndecan-2-dependent process.
Next, we examined the involvement of neurofi bromin and Ena/VASP proteins in spine formation by again expressing NF1 Figure 9 . Ena/VASP proteins are important for syndecan-2 signaling in fi lopodia formation. (A) Syndecan-2 was cotransfected with EGFP-Mena, -VASP, and -EVL into cultured hippocampal neurons at 1 DIV. Cells were harvested for staining using syndecan-2G and GFP antibodies at 4-5 DIV. Syndecan-2 was viewed by AlexaFluor594 in red; Ena/VASP proteins were viewed by AlexaFluor488 in green. (B) Syndecan-2 overexpression induces VASP phosphorylation. HEK cells were transfected with syndecan-2 and vector control and subjected to immunoblotting using antibodies recognizing phosphorylated S157 and S239 of VASP and other proteins as indicated. Arrowheads point to phosphorylated VASP; the arrow points to unphosphorylated VASP. (C) Syndecan-2 was cotransfected with the AP4-mito or FP4-mito construct into cultured hippocampal neurons. Filopodia formation was monitored using the syndecan-2 staining pattern. (D) Cumulative probability distributions of the fi lopodia density in C. Bars, 10 μm.
shRNA and FP4-mito constructs, respectively, in hippocampal neurons at 11-12 DIV. The spine density of mature neurons was then examined at 16-17 DIV. Compared with nonsilencer control, the NF1 shRNA construct signifi cantly reduced spine density along dendrites of mature hippocampal neurons (P < 0.001; Fig. 10, C and D) , supporting the role of neurofi bromin in dendritic spine formation. In the investigation targeting Ena/VASP proteins, expression of the FP4-mito construct also inhibited spine formation in mature hippocampal neurons (Fig. 10, E and F) , supporting an involvement of Ena/VASP proteins in spine formation. In conclusion, these results indicated that neurofi bromin and Ena/VASP proteins contribute to dendritic spine formation, perhaps through the regulation of fi lopodia formation.
Discussion
Using HEK cells and cultured hippocampal neurons as models, we have demonstrated that the neurofi bromin-PKA-Ena/VASP pathway mediates the downstream signaling of syndecan-2. This study shows that syndecan-2 itself can deliver a signal to cells to change cell morphology. Our results also provide the fi rst evidence that both neurofi bromin and Ena/VASP proteins are involved in dendritic spine formation.
For cell signaling, syndecans are fi rst identifi ed as coreceptors for growth and differentiation factors. However, the previous studies indicated that syndecans are capable of activating intracellular signaling pathways directly via their short cytoplasmic domains. The fi rst example of this was seen with syndecan-4; overexpression of this protein in CHO cells promotes focal adhesion assembly (Longley et al., 1999) . The V region of syndecan-4, which binds to phosphatidylinositol-4,5-bisphosphate and activates PKCα, is critical for this function (Oh et al., 1998) . Another study showed that the pleiotrophin/heparinbinding growth-associated molecule, which promotes neurite outgrowth in developing neurons, binds to syndecan-3 to induce a syndecan-3-Src-cortactin interaction (Kinnunen et al., 1998) .
In the present study, we have demonstrated a third signaling pathway involving a direct interaction of syndecan-2 with the neurofi bromin-PKA-Ena/VASP pathway. Overexpression of syndecan-2 induces fi lopodia formation via PKA activity, which is mediated by neurofi bromin, and thus regulates the function of Ena/VASP proteins in fi lopodia formation. In contrast to the Figure 10 . The syndecan-2-neurofi bromin-Ena/VASP signaling pathway is involved in dendritic spinogenesis. (A, C, and E) Dissociated hippocampal neurons were transfected with syndecan-2, -2△3, or -2△C1 at 1-2 DIV and fi xed at 8-9 DIV for immunostaining (A). They were also cotransfected with EGFP-actin and nonsilencer or NF1 shRNA (C) and either DsRed-actin or myc-actin and AP4-mito or FP4-mito at 11-12 DIV and fi xed at 16-17 DIV (E). In A, immunostaining using syndecan-2G antibodies was performed to outline the cellular morphology of transfected neurons. Two representative images are shown. For syndecan-2-expressing neurons, double staining with the presynaptic marker synaptophysin (SVP38) was performed. Some of the syndecan-2-induced dendritic spines were adjacent to the SVP38-positive signal, which are marked by arrowheads. In C and E, the EGFP-, DsRed-, or myc-actin patterns were viewed to assess cell morphology. heparin-binding growth-associated molecule-syndecan-3 pathway, the need for a specifi c ligand for the activation of syndecan-2 has not been clarifi ed. In our system, overexpression of syndecan-2 is suffi cient to induce downstream signaling; however, it cannot be ruled out that an unknown syndecan-2 ligand is present in our culture systems.
Currently, it is also unclear how the overexpression of syndecan-2 enhances the ability of neurofi bromin to activate PKA. Perhaps interaction with syndecan-2 changes the conformation of neurofi bromin, allowing the activation of adenylyl cyclase. Because syndecans form dimers (and perhaps multimers) via their transmembrane domains and there are two separate syndecan-2-interacting sites in neurofi bromin (Hsueh et al., 2001) , a single neurofi bromin molecule may simultaneously interact with a syndecan-2 dimer. This interaction might fi x the neurofi bromin molecule in a conformation that favors the activation of adenylyl cyclase. Therefore, increases in the level of syndecan-2 might fi x more neurofi bromin molecules in a conformation that activates adenylyl cyclase. More investigation is needed to explore this possibility.
The deletion analyses showed that syndecan-2∆32 and -2∆C1 mutants were unable to promote fi lopodia formation. Retention of mutants in the cytoplasm cannot explain this phenotype. Our syndecan-2G antibody recognized the ectodomain of syndecan-2 (unpublished data). It stained both syndecan-2and -2∆32-expressing cells in the absence of permeabilization (unpublished data), indicating the normal surface expression of syndecan-2∆32. Moreover, the expression levels of both syndecan-2∆C1 and -2∆32 were comparable with that of wildtype syndecan-2 ( Fig. S2 C) . The loss of fi lopodia formation with these mutants is also unlikely to be the result of defects in protein expression or subcellular distribution. It suggests that the regions missing in these deletion constructs are important for fi lopodia formation.
The current fi ndings indicate that the PKA pathway is essential for syndecan-2-induced fi lopodia formation. However, PKA activation itself is not suffi cient for fi lopodia formation. It suggests that syndecan-2 overexpression is likely to activate multiple signaling pathways that are all required for dendritic spine formation. Consistent with this speculation, the Ras pathway, which is also regulated by neurofi bromin, has been shown to contribute to dendritic spine formation (Wu et al., 2001; Vazquez et al., 2004; Kumar et al., 2005) . It is possible that the Ras and PKA pathways downstream of syndecan-2/neurofi bromin coordinate and regulate dendritic spinogenesis. Alternatively, the ectodomain of syndecan-2 involved in cell-cell or cell-matrix interaction may also be essential for fi lopodia outgrowth. Without adhesion via the syndecan-2 ectodomain, fi lopodial protrusions may not be stable. The observation that overexpression of the entire cytoplasmic domain of syndecan-2 failed to promote fi lopodia formation (unpublished data) also supports the idea that the ectodomain of syndecan-2 is required in this process. More investigations are required to resolve this issue.
Although the cytoplasmic domain of syndecan-2 is short, it interacts with several proteins. Even the complex formation of neurofi bromin, syndecan, and CASK has been shown. However, it is unclear whether there is any cross talk between CASK and neurofi bromin. CASK apparently has no infl uence on the fi lopodia formation activity of neurofi bromin because deletion of the CASK-binding site (EFYA motif) on syndecan-2 did not affect fi lopodia formation. Instead of being part of the same process, it seems likely that the complex formation of CASK, syndecan-2, and neurofi bromin serves to achieve two sequential processes: fi lopodia formation and dendritic spine maturation. The interaction of syndecan-2 with neurofi bromin initiates fi lopodia formation, and the interaction with CASK may further transform fi lopodia to dendritic spines. The results of the analysis of cytoplasmic deletion mutants of syndecan-2 in fi lopodia and spine formation support this speculation. Ethell et al. (2001) demonstrated that EphB2 receptor tyrosine kinase phosphorylates the tyrosine residues Y189 and Y201 in the C1 and V regions of syndecan-2, respectively. EphB2 phosphorylation is required for syndecan-2 clustering on dendrites and the induction of mature spines. When both of the residues Y189 and Y201 are mutated, the mutant syndecan-2 proteins no longer cluster and promote spinogenesis (Ethell et al., 2001) . However, EphB2 phosphorylation seems only to affect spine formation but not fi lopodia formation because fi lopodia formation is not affected in neurons expressing syndecan-2 Y189F/Y201F mutant (Ethell et al., 2001) . In addition, overexpression of an EphB2 kinase-dead mutant in hippocampal neurons prevents spine but not fi lopodia formation (Ethell et al., 2001) . In addition to tyrosine phosphorylation, the V region of the syndecan-2 cytoplasmic domain contains two PKC phosphorylation sites. Xenopus laevis syndecan-2 is phosphorylated by PKC and is critical for establishing left-right asymmetry during early development (Kramer et al., 2002) . However, PKC inhibitors did not prevent fi lopodia formation induced by syndecan-2, suggesting that PKC phosphorylation on the V region only regulates the function of syndecan-2 at an early embryonic stage for left-right decision. Neither EphB2 nor PKC phosphorylation regulates syndecan-2-induced fi lopodia formation.
In conclusion, our studies show clearly that syndecan-2 plays an active role in delivering a biochemical signal into cells. Syndecan-2 remodels the cytoskeleton and promotes the formation of fi lopodia via the neurofi bromin-PKA-Ena/ VASP pathway.
Materials and methods
Hippocampal neuronal culture and analysis of dendritic fi lopodia/spine formation Hippocampal neuronal cultures were performed as described previously (Wang et al., 2004; Lin et al., 2006) with the minor modifi cation that 300,000 cells per well were plated in 12-well plates containing poly-L-lysine-coated coverslips in each well. Transfection using calcium phosphate precipitation was performed to deliver the plasmid DNA into neurons. To study the effect of syndecan-2 on fi lopodia formation, transfection of syndecan-2 was performed at 1-2 DIV, and immunostaining was performed at 4-5 DIV. Filopodia formation was determined by the density of protrusions emerging from neurites with a length between 0.75 and 10 μm. The protrusions longer than 10 μm were recognized as dendritic branches. To study the effect of syndecan-2 on spine formation at 8-9 DIV, the length of individual protrusions and protrusion density were measured. Only the protrusions longer than 0.5 μm were counted. To study intrinsic dendritic spine formation, transfection was performed at 11-12 DIV, and immunofl uorescence staining was performed at 16-17 DIV. The densities of protrusions longer than 0.5 μm were determined.
All results were shown in cumulative probability distribution and statistically analyzed using the Kolmogorov-Smirnov test. Signifi cance was determined based on the D and corresponding p-values. All of the data obtained in Kolmogorov-Smirnov tests and sample sizes of each experiment are summarized in the supplemental text (available at http://www .jcb.org/cgi/content/full/jcb.200608121/DC1).
Transfection of COS and HEK cells, immunoblotting, immunoprecipitation, and analysis of fi lopodia density
The details for transfection of COS cells and immunoblotting of syndecan-2 and neurofi bromin have been previously described (Hsueh and Sheng, 1999a,b; Hsueh et al., 2001) . The conditions for HEK293T cell transfection using LipofectAMINE (Invitrogen) were identical to those used for COS cells. Immunoprecipitation using COS cell extract was performed as described previously (Hsueh and Sheng, 1999b) with some modifi cations. In brief, 1 d after transfection, cells were washed twice in PBS and treated with 2 mM dithiobis[succinimidylpropionate] (Pierce Chemical Co.) in PBS at 37°C for 30 min. Free dithiobis[succinimidylpropionate] was then removed by washing twice with PBS. Cells were lysed with radioimmunoprecipitation assay buffer and immunoprecipitated using syndecan-2G antibody. To determine the fi lopodia density on HEK cell, 24 h after transfection, cells were harvested for immunostaining using syndecan-2G antibodies. Filopodia revealed by syndecan-2G signals on the cell surface were counted and divided by the length of cell circumference. For each treatment, a fi lopodia density of >50 cells was measured. Cumulative probability distribution was shown, and the Kolmogorov-Smirnov test was used to check the signifi cance. All of the data obtained in Kolmogorov-Smirnov tests and sample sizes of each experiment are summarized in the supplemental text.
Antibodies
A rabbit polyclonal syndecan-2 antibody (syndecan-2G) was generated using a GST-syndecan-2 (residues 33-211) recombinant protein as antigen. The antibody was affi nity purifi ed using protein A-Sepharose. The monoclonal antibody against GFP was purchased from Invitrogen. VASP antibody was obtained from BD Biosciences. Antibodies against phosphorylated S157 and S239 of VASP were purchased from Chemicon.
Immunofl uorescence analysis and time-lapse study
Cells were washed twice in PBS and fi xed in PBS containing 4% PFA and 4% sucrose for 10 min at room temperature. After washing, HEK cells were blocked with 1% BSA/1% normal horse serum, and cultured neurons were blocked with 10% BSA for 1 h. The primary antibody was diluted in PBS containing 0.5% BSA for HEK and PBS containing 3% BSA for neurons and was added to cells for a further 1-2-h incubation. After washing, the AlexaFluor488-or -594-conjugated secondary antibody (Invitrogen) was added and incubated for 1-2 h. Samples were then analyzed at room temperature with either a fl uorescence microscope (DM RE; Leica) with a PLAPO 63× NA 1.32 oil objective lens (Leica) or a confocal microscope (LSM510; Carl Zeiss MicroImaging, Inc.) with a plan-Apochromat 63× NA 1.25 oil objective lens (Carl Zeiss MicroImaging, Inc.). For regular fl uorescence microscopy, images were acquired with a cooled CCD camera (RTE/CCD-1300-Y/HS; Roper Scientifi c) operated using MetaMorph software (Molecular Devices). For confocal microscopy, the images were acquired using a laser-scanning microscope system (LSM510; Carl Zeiss MicroImaging, Inc.). Results were then processed for publication using Photoshop software (Adobe) with a minimal adjustment of brightness or contrast applied to the whole images.
For the time-lapse study, syndecan-2 and GFP-actin were cotransfected into HEK293T cells at a ratio of 8:1. 18 h after transfection, the dynamic of syndecan-2-induced fi lopodia was monitored by GFP-actin pattern in an open chamber under a fl uorescence microscope (DMRE; Leica) with an HCX APO 63× 0.90-W water objective lens. Images were acquired with the Roper Scientifi c cooled CCD camera for at least 10 min. The velocity of the fi lopodia movement and positions of the fi lopodia tips were analyzed by MetaMorph software.
Construction of plasmids
Plasmid construction for the mammalian expression of syndecans 1-4 has been previously described (Hsueh et al., 1998) . EGFP-Mena, EGFP-VASP, EGFP-EVL, FP4-mito, and AP4-mito constructs (Bear et al., 2000; Loureiro et al., 2002) were provided by F.B. Gertler (Massachusetts Institute of Technology, Cambridge, MA). PKI construct was provided by H.-M. Shih (Institute of Biomedical Science, Academia Sinica, Taipei, Taiwan).
To construct the C-terminal deletion mutants syndecan-2∆3, -2∆20, and -2∆32, the respective syndecan-2 cDNA fragments were PCR amplifi ed and subcloned into the EcoRI site of the vector GW1-cytomegalovirus.
The same sense oligonucleotide primer (5′-C G G A A T T C A T C G G G T A C G A-G C C A C G -3′) was used for PCR construction of all three mutants. The antisense oligonucleotide primers were as follows: (1) for syndecan-2∆3,
5′-C G G A A T T C C T A C T C C T T A G T G G G T G C C T T C T -3′; (2) for syndecan-2∆20, 5′-C G G A A T T C C T A A A G G T C G T A G C T T C C T T C G T C T T T C T T C -3′; and (3) for syndecan-2∆32, 5′-C G G A A T T C C T A G T A C A C C A A C A A C A G G A T-G
A G -3′. The underlined sequences are EcoRI sites that were appended for cloning purposes. To construct the syndecan-2∆C1 mutant, a pair of primers (5′-C G G G T A C C A T G C G G G T A C G A G C C A C G -3′ and 5′-G T A C A C C A-A C A A C A G G A T G A G -3′) were used to amplify the region containing the extracellular and transmembrane domains. A pair of primers (5′-G A C C T T-
G G A G A A C G C A A A C C G -3′ and 5′-C G G A A T T C T T A T G C A T A A A A C T C C T T-
A G T -3′) was used to amplify the variable and C2 domains. These two fragments were ligated by blunt-end ligation and subcloned into the KpnI and EcoRI sites of the vector GW1-cytomegalovirus. A QuikChange XL Site-Directed Mutagenesis kit (Stratagene) was used for generating the syndecan-2 RK/AA, KD/AA, and silent mutants. For syndecan-2 RK/AA, the pair of primers 5′-G
T T G G T G T A C C G C A T G G C G G C G A A A G A C G A A G G A-A G C T A C -3′ and 5′-G C T T C C T T C G T C T T T C G C C G C C A T G C G G T A C A C C A-A C A A C -3′ was used for site-directed mutagenesis. For syndecan-2 KD/AA, the primers 5′-G T A C C G C A T G C G G A A G G C A G C C G A A G G A A G C T A C G-A C C T T G -3′ and 5′-G T C G T A G C T T C C T T C G G C T G C C T T C C G C A T G C G G T-
A C A C -3′ were used. For the syndecan-2 silent mutant, the pair of primers
5′-A G C A G C T C C A T T G A G G A A G C T T C A G G G T T G T A T C C T A T T G -3′ and 5′-C A A T A G G A T A C A A C C C T G A A G C T T C -3′ was used. The underlined residues indicate the mutated sites.
For vector-based syndecan-2 RNAi construction, a pair of oligonucleotides (syndecan-2is, 5′-
G A T C C C C G C T T C A G G A T T A T A T C C T A T T C-A A G A G A T A G G A T A T A A T C C T G A A G C T T T T T G G A A A -3′; syndecan-2iAs, 5′-G C T T T T C C A A A A A G C T T C A G G A T T A T A T C C T A T C T C T T G A A T A G G A T A T A-A T C C T G A A G C G G G -3′
) was annealed and inserted into the BgIII and HindIII sites of the siRNA expression vector pSUPER.neo+GFP (OligoEngine). The underlined residues correspond to the nucleotide residues 148-166 of rat syndecan-2 cDNA. The NF1 shRNA expression constructs 27 and 32 in vector pSM2c were purchased from Open Biosystems and corresponded to the nucleotide residues 8,416-8,436 and 3,349-3,370 of human type I NF1, respectively. Because residues 8,416-8,436 are identical in the human and rat NF1 genes, construct 27 can also knock down rat NF1. Nonsilencer control expressing and shRNA sharing no homology with any known mammalian genes were also purchased from Open Biosystems. The Jn and Pn mammalian expression constructs were created by excising the Jn and Pn fragments from the Jn-pGAD10 and Pn-pGAD10 constructs (Hsueh et al., 2001) with EcoRI and subcloning them into the EcoRI site of a modifi ed vector GW1 containing a myc cassette. Plasmids EGFP and EGFP-actin were purchased from CLONTECH Laboratories, Inc. For myctagged actin, actin cDNA was digested from EGFP-actin and subcloned into the BglII site of the vector myc-GW1.
PKA activity assay
HEK293T cells were transfected with the vector control or a variety of syndecan-2 constructs. 18 h after transfection, cells were harvested for PKA activity analysis using an ELISA kit from Calbiochem. Equal protein amounts of cell extracts were used.
Animals and housing
All animal experiments were performed with the approval of and in strict accordance with the guidelines of the Academia Sinica Institutional Animal Care and Utilization Committee and the Republic of China Council of Agriculture Guidebook for the Care and Use of Laboratory Animals. Pregnant rats were housed individually and killed by CO 2 inhalation. All efforts were made to minimize animal suffering and to reduce the number of animals required. Fig. S1 is the characterization of syndecan-2 and neurofi bromin RNAi constructs and the dominant-negative mutant of neurofi bromin. Fig. S2 shows the specifi city of syndecan-2 antibody and expression of syndecan-2 wild-type and mutant constructs. Fig. S3 shows that PKC and PI3K are not involved in fi lopodia formation downstream of syndecan-2. Fig. S4 shows that Ena/VASP proteins are the downstream effectors of PKA activated by syndecan-2 in HEK293T cells. Supplemental text contains the data obtained in Kolmogorov-Smirnov tests, including D and corresponding p-values and sample sizes of each experiment. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200608121/DC1.
Online supplemental material
